NewsRx

Search our medical news database

Product Licensing

Solvias acquires exclusive license for C-N-coupling technology from Yale University

Published in Biotech Business Week, March 20th, 2006

Solvias has exclusively licensed a highly efficient C-N-coupling technology for aromatic and hetero-aromatic chlorides, bromides and sulfonates with amines and imines from Yale University (U.S. patents 5,977,361 and US 6,235,938 B1).

The licensing of the technology extends Solvias' technology portfolio and is immediately available to customers for industrial-scale manufacturing.

Buchwald-Hartwig Amination reactions (C-N-coupling reactions) are used in the pharmaceutical, agrochemical and speciality chemicals industry because they are very high yielding and utilize relatively inexpensive starting materials such as primary and secondary amines or...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook